EUROPE BIOCHIPS MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

EUROPE BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Material, End Users And Geography | Forecasts 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Europe biochips market is expected to display an upward trend and is estimated to grow at a CAGR of 18.91% during the forecasted years of 2019 to 2027.

The countries covered in the Europe biochips market are:

o    United Kingdom

o     Germany

o     France

o     Italy

o     Spain 

o     Russia 

o     Rest of Europe

Europe biochips market is expected to display an upward trend and is estimated to grow at a CAGR of 18.91%

We provide additional customization based on your specific requirements. Request For Customization  

Biochips finds its uses in areas like genomics (for cancer diagnosis and treatment), drug discovery, gene expression, point of care & In Vitro diagnosis and proteomics. Germany & the UK are the most significant economies in the European region for biochips market. Germany holds the largest share in the European biochips market. The biochips market is studied based on various segments, which include type, substrate material, and end users. 

The report of the biochips market by Triton provides the market insights of DNA chips, protein chips, and lab on chip substrate materials. The report also provides details about Porter’s five force analysis, market definition, market attractiveness index, vendor scorecard, regulatory framework, forecast, and market sizing of biochips market in the European region, followed by the market drivers, restraints, opportunities and challenges. 

The increasing application of biochips in biotechnology and biomedical fields is rapidly driving the demand of the biochips market in the European region. The major driving factor for biochips market in Europe is the increasing adoption of biochips in microarrays and proteomics. The availability of alternative technologies is the key restraint hampering the biochips market growth in the region. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    BIOCHIPS MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.3. EVOLUTION & TRANSITION OF BIOCHIPS

2.4. PORTER'S FIVE FORCE ANALYSIS

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY IMPACT ANALYSIS

2.10.            MARKET OPPORTUNITY INSIGHTS

2.11.            INDUSTRY PLAYER POSITIONING

2.12.            KEY MARKET STRATEGIES

2.13.            MARKET DRIVERS

2.13.1.                GROWTH IN PERSONALIZED MEDICINES

2.13.2.                RISING INCIDENCES & TREATMENT OF CANCER

2.13.3.                CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE

2.13.4.                INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D

2.14.            MARKET RESTRAINTS

2.14.1.                INEQUALITY IN HEALTHCARE ACCESS

2.14.2.                INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS

2.14.3.                COMPLEXITY OF BIOLOGICAL SYSTEMS

2.15.            MARKET OPPORTUNITIES

2.15.1.                DEVELOPMENTS IN BIOCHIPS TECHNOLOGY

2.15.2.                WIDENING APPLICATION AREAS OF BIOCHIPS

2.16.            MARKET CHALLENGES

2.16.1.                AVAILABILITY OF SUBSTITUTE TECHNOLOGIES

2.16.2.                UNCLEAR REGULATORY GUIDELINES

2.16.3.                COST CONSTRAINTS

3.    BIOCHIPS INDUSTRY OUTLOOK – BY TYPE

3.1. DNA CHIPS

3.1.1.   AGRICULTURAL BIOTECHNOLOGY

3.1.2.   CANCER DIAGNOSTICS & TREATMENT

3.1.3.   DRUG DISCOVERY

3.1.4.   GENE EXPRESSION

3.1.5.   GENOMICS

3.1.6.   SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING

3.1.7.   OTHER DNA CHIPS

3.2. LAB ON A CHIP

3.2.1.   CLINICAL DIAGNOSTICS

3.2.2.   DRUG DISCOVERY

3.2.3.   GENOMICS

3.2.4.   POINT OF CARE & IN VITRO DIAGNOSIS

3.2.5.   PROTEOMICS

3.2.6.   OTHER LAB ON A CHIP

3.3. PROTEIN CHIPS

3.3.1.   DIAGNOSTICS

3.3.2.   DRUG DISCOVERY

3.3.3.   EXPRESSION PROFILING

3.3.4.   HIGH THROUGHPUT SCREENING

3.3.5.   PROTEOMICS

3.3.6.   OTHER PROTEIN CHIPS

3.4. OTHER CHIPS

3.4.1.   CELL ARRAYS

3.4.2.   TISSUE ARRAYS

4.    BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL

4.1. GLASS

4.2. POLYMERS

4.3. SILICON

4.4. OTHER SUBSTRATE MATERIALS

5.    BIOCHIPS INDUSTRY OUTLOOK - BY END USER

5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

5.2. HOSPITALS AND DIAGNOSTICS CENTERS

5.3. ACADEMIC AND RESEARCH INSTITUTE

6.    BIOCHIPS INDUSTRY - EUROPE

6.1. UNITED KINGDOM

6.2. GERMANY

6.3. FRANCE

6.4. ITALY

6.5. SPAIN

6.6. RUSSIA

6.7. REST OF EUROPE

7.    COMPETITIVE LANDSCAPE

7.1. AGILENT TECHNOLOGY INC.

7.2. BIOCHAIN INSTITUTE INC.

7.3. BIOMERIEUX SA

7.4. BIO-RAD LABORATORIES INC.

7.5. CEPHEID INC.

7.6. CYBRDI INC.

7.7. FLUIDIGM CORPORATION

7.8. GAMIDA FOR LIFE GROUP

7.9. ILLUMINA INC.

7.10.            IMGENEX

7.11.            MERCK GMBH

7.12.            ORIGENE TECHNOLOGIES INC.

7.13.            PERKINELMER INC.

7.14.            SAMSUNG ELECTRONICS INC.

7.15.            THERMO FISHER SCIENTIFIC INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

     8.3. RESEARCH METHODOLOGY

List of table

TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET       

TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET

TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET

TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET

TABLE 5. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017          

TABLE 6. EUROPE BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 7. EUROPE BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) 

TABLE 8. EUROPE BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)           

TABLE 9. EUROPE BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1. EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)      

FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET

FIGURE 3. KEY IMPACT ANALYSIS

FIGURE 4. TIMELINE OF BIOCHIPS

FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018

FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018   

FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET   

FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%)

FIGURE 9. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE        

FIGURE 10. EUROPE BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)         

FIGURE 11. EUROPE DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)

FIGURE 12. EUROPE DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 13. EUROPE DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)           

FIGURE 14. EUROPE DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)      

FIGURE 15. EUROPE DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)       

FIGURE 16. EUROPE DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)       

FIGURE 17. EUROPE DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) 

FIGURE 18. EUROPE BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)  

FIGURE 19. EUROPE LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 20. EUROPE LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 21. EUROPE LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)

FIGURE 22. EUROPE LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION)

FIGURE 23. EUROPE LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)           

FIGURE 24. EUROPE LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)

FIGURE 25. EUROPE BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 26. EUROPE PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 27. EUROPE PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 28. EUROPE PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)

FIGURE 29. EUROPE PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)

FIGURE 30. EUROPE PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)

FIGURE 31. EUROPE PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 32. EUROPE BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 33. EUROPE OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 34. EUROPE OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 35. EUROPE BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)   

FIGURE 36. EUROPE BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)

FIGURE 37. EUROPE BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)

FIGURE 38. EUROPE BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)

FIGURE 39. EUROPE BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)

FIGURE 40. EUROPE BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)

FIGURE 41. EUROPE BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)

FIGURE 42. EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2017 & 2026 (IN %)                    

FIGURE 43. UNITED KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)          

FIGURE 44. GERMANY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 45. FRANCE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)    

FIGURE 46. ITALY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)          

FIGURE 47. SPAIN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)         

FIGURE 48. RUSSIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)      

FIGURE 49. REST OF EUROPE BIOCHIPS MARKET, (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;